MYRIAD GENETICS INC (MYGN) — Revenue

Annual figures by fiscal year, from SEC filings.

2015: $722.50M2016: $740.50M2017: $728.70M2018: $743.70M2019: $851.10M2020: $557.10M2021: $690.60M2022: $678.40M2023: $753.20M2024: $837.60M2025: $824.50M$824.50M
2015Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$824.50M-1.6%
2024$837.60M+11.2%
2023$753.20M+11.0%
2022$678.40M-1.8%
2021$690.60M+24.0%
2020$557.10M-34.5%
2019$851.10M+14.4%
2018$743.70M+2.1%
2017$728.70M-1.6%
2016$740.50M+2.5%
2015$722.50M